Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015; 28(3-4):251-63. doi: 10.1515/jpem-2014-0384. PMID: 25581748.
Nkonge KM, Nkonge DK, Nkonge TN. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol. 2020; 6:20. https://doi.org/10.1186/s40842-020-00112-5.
Juszczak A, Pryse R, Schuman A, Owen KR. When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management. Br J Gen Pract. 2016; 66(647): e457-e459. doi: 10.3399/bjgp16X685537.
Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012 Jul; 49(7): 433-6. doi: 10.1136/jmedgenet-2012-100918.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5): 405-24. doi: 10.1038/gim.2015.30.
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13:59. https://doi.org/10.1186/1471-2431-13-59.
Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HAJ, Steele AM et al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem. 2005; 280(14): 14105-13. doi: 10.1074/jbc.M413146200
Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016 Nov; 39(11): 1879-1888. doi: 10.2337/dc16-0645.
Arden C, Trainer A, de la Iglesia N, Scougall ET, Gloyn AL, Lange AJ et al. Cell biological assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity. Diabetes. 2007 Jul; 56(7): 1773-82. doi: 10.2337/db06-1151.
Ralph EC, Sun S. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type. Biochemistry. 2009 Mar 24; 48(11): 2514-21. doi: 10.1021/bi900020n.